Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Abstract 3464: CEBPD (C/EBPδ) acts as a tumor suppressor in hormone receptor positive breast cancer cells and may serve as biomarker to predict the need for adjuvant therapy.

Daniel Y. Mendoza-Villanueva, Suryun Kim, H.Raza Ali, Shikha Sharan, Tapasree R. Sarkar, Carlos Caldas, Göran Landberg, Esta Sterneck

Cancer Res (2013) 73 (8_Supplement): 3464.

https://doi.org/10.1158/1538-7445.AM2013-3464

Published: 15 April 2013

View articletitled, Abstract 3464: CEBPD (C/EBPδ) acts as a tumor suppressor in hormone receptor positive breast cancer cells and may serve as biomarker to predict the need for adjuvant therapy.

Journal Articles

Abstract 3141: Analysis of the endocrine treatment predictive protein HOXB13 in premenopausal breast cancer

Piiha-Lotta Jerevall, Agneta Jansson, Ann-Christine Källström, Göran Landberg, Mårten Fernö, Olle Stål

Cancer Res (2011) 71 (8_Supplement): 3141.

https://doi.org/10.1158/1538-7445.AM2011-3141

Published: 15 April 2011

View articletitled, Abstract 3141: Analysis of the endocrine treatment predictive protein HOXB13 in premenopausal breast cancer

Journal Articles

Abstract 3993: Stromal and epithelial microRNA signatures of early breast lesions linked to cancer progression

Sofie Nilsson, Craig Allred, Anthony Howell, Göran Landberg

Cancer Res (2011) 71 (8_Supplement): 3993.

https://doi.org/10.1158/1538-7445.AM2011-3993

Published: 15 April 2011

View articletitled, Abstract 3993: Stromal and epithelial microRNA signatures of early breast lesions linked to cancer progression

Journal Articles

Abstract 3879: YAP (Yes-associated protein), a proposed tumor suppressor in breast cancer, is regulated by cyclin D1

Sophie Lehn, Nicholas P. Tobin, Göran Landberg

Cancer Res (2010) 70 (8_Supplement): 3879.

https://doi.org/10.1158/1538-7445.AM10-3879

Published: 15 April 2010

View articletitled, Abstract 3879: YAP (Yes-associated protein), a proposed tumor suppressor in breast cancer, is regulated by cyclin D1

Journal Articles

Abstract 2077: MicroRNA signature of hyperplastic enlarged lobular units (HELU) from patients with high risk of breast cancer

Sofie Nilsson, Göran Landberg

Cancer Res (2010) 70 (8_Supplement): 2077.

https://doi.org/10.1158/1538-7445.AM10-2077

Published: 15 April 2010

View articletitled, Abstract 2077: MicroRNA signature of hyperplastic enlarged lobular units (HELU) from patients with high risk of breast cancer

Journal Articles

Hypoxia-Inducible Factor-2α Correlates to Distant Recurrence and Poor Outcome in Invasive Breast Cancer

Karolina Helczynska, Anna-Maria Larsson, Linda Holmquist Mengelbier, Esther Bridges, Erik Fredlund, Signe Borgquist, Göran Landberg, Sven Påhlman, Karin Jirström

Cancer Res (2008) 68 (22): 9212–9220.

https://doi.org/10.1158/0008-5472.CAN-08-1135

Published: 14 November 2008

View articletitled, Hypoxia-Inducible Factor-2α Correlates to Distant Recurrence and Poor Outcome in Invasive Breast Cancer

Includes: Supplementary data

Journal Articles

Cyclin E Overexpression Obstructs Infiltrative Behavior in Breast Cancer: A Novel Role Reflected in the Growth Pattern of Medullary Breast Cancers

Pontus Berglund, Maria Stighall, Karin Jirström, Signe Borgquist, Anita Sjölander, Ingrid Hedenfalk, Göran Landberg

Cancer Res (2005) 65 (21): 9727–9734.

https://doi.org/10.1158/0008-5472.CAN-04-3984

Published: 01 November 2005

View articletitled, Cyclin E Overexpression Obstructs Infiltrative Behavior in Breast Cancer: A Novel Role Reflected in the Growth Pattern of Medullary Breast Cancers

Journal Articles

Adverse Effect of Adjuvant Tamoxifen in Premenopausal Breast Cancer with Cyclin D1 Gene Amplification

Karin Jirström, Maria Stendahl, Lisa Rydén, Åsa Kronblad, Pär-Ola Bendahl, Olle Stål, Göran Landberg, The South Swedish and Southeast Swedish Breast Cancer Groups.

Cancer Res (2005) 65 (17): 8009–8016.

https://doi.org/10.1158/0008-5472.CAN-05-0746

Published: 01 September 2005

View articletitled, Adverse Effect of Adjuvant Tamoxifen in Premenopausal Breast Cancer with Cyclin D1 Gene Amplification

Journal Articles

A Novel Localization of the G-Protein-Coupled CysLT₁ Receptor in the Nucleus of Colorectal Adenocarcinoma Cells

Christian Kamp Nielsen, Joan I.A. Campbell, John F. Öhd, Matthias Mörgelin, Kristian Riesbeck, Göran Landberg, Anita Sjölander

Cancer Res (2005) 65 (3): 732–742.

https://doi.org/10.1158/0008-5472.732.65.3

Published: 10 February 2005

View articletitled, A Novel Localization of the G-Protein-Coupled CysLT1 Receptor in the Nucleus of Colorectal Adenocarcinoma Cells

Journal Articles

Biomarker identification via re-analysis of DNA microarray data and use of tissue microarrays: A focus on breast cancer.

Sallyann O’ Brien, Michael J. Duffy, Edward J. Fox, Aedín C. Culhane, Ailis Fagan, Sean S. Costello, Daniel J. Johnston, Graham Dodrill, Amanda H. McCann, Peter A. Dervan, Desmond G. Higgins, Donal G. O’ Shea, Göran Landberg, William M. Gallagher

Cancer Res (2004) 64 (7_Supplement): 795.

Published: 01 April 2004

View articletitled, Biomarker identification via re-analysis of DNA microarray data and use of tissue microarrays: A focus on breast cancer.

Journal Articles

Invade or Proliferate? Two Contrasting Events in Malignant Behavior Governed by p16^INK4a and an Intact Rb Pathway Illustrated by a Model System of Basal Cell Carcinoma

Sofie Svensson, Kristina Nilsson, Anita Ringberg, Göran Landberg

Cancer Res (2003) 63 (8): 1737–1742.

Published: 15 April 2003

View articletitled, Invade or Proliferate? Two Contrasting Events in Malignant Behavior Governed by p16INK4a and an Intact Rb Pathway Illustrated by a Model System of Basal Cell Carcinoma

Journal Articles

Hypoxia Promotes a Dedifferentiated Phenotype in Ductal Breast Carcinoma in Situ

Karolina Helczynska, Åsa Kronblad, Annika Jögi, Elise Nilsson, Siv Beckman, Göran Landberg, Sven Påhlman

Cancer Res (2003) 63 (7): 1441–1444.

Published: 01 April 2003

View articletitled, Hypoxia Promotes a Dedifferentiated Phenotype in Ductal Breast Carcinoma in Situ

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract 3464: CEBPD (C/EBPδ) acts as a tumor suppressor in hormone receptor positive breast cancer cells and may serve as biomarker to predict the need for adjuvant therapy.

Abstract 3141: Analysis of the endocrine treatment predictive protein HOXB13 in premenopausal breast cancer

Abstract 3993: Stromal and epithelial microRNA signatures of early breast lesions linked to cancer progression

Abstract 3879: YAP (Yes-associated protein), a proposed tumor suppressor in breast cancer, is regulated by cyclin D1

Abstract 2077: MicroRNA signature of hyperplastic enlarged lobular units (HELU) from patients with high risk of breast cancer

Hypoxia-Inducible Factor-2α Correlates to Distant Recurrence and Poor Outcome in Invasive Breast Cancer

Cyclin E Overexpression Obstructs Infiltrative Behavior in Breast Cancer: A Novel Role Reflected in the Growth Pattern of Medullary Breast Cancers

Adverse Effect of Adjuvant Tamoxifen in Premenopausal Breast Cancer with Cyclin D1 Gene Amplification

A Novel Localization of the G-Protein-Coupled CysLT₁ Receptor in the Nucleus of Colorectal Adenocarcinoma Cells

Biomarker identification via re-analysis of DNA microarray data and use of tissue microarrays: A focus on breast cancer.

Invade or Proliferate? Two Contrasting Events in Malignant Behavior Governed by p16^INK4a and an Intact Rb Pathway Illustrated by a Model System of Basal Cell Carcinoma

Hypoxia Promotes a Dedifferentiated Phenotype in Ductal Breast Carcinoma in Situ

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only